Keyphrases
Complementary DNA (cDNA)
100%
Genomic DNA (gDNA)
100%
PCR-SSCP
100%
Single-strand Conformation Polymorphism Analysis
100%
Primary Prostate Cancer
100%
Prostate Carcinoma
45%
Quantitative PCR
36%
P53 Gene
36%
TP53 mutation
36%
SSCP Analysis
36%
PCR Analysis
27%
PCR Products
27%
Carcinoma
27%
DNA PCR
27%
Primary Carcinoma
18%
Nucleotide Sequence
9%
DNA Sequencing
9%
Clinical Outcomes
9%
Exon
9%
Protein-coding Genes
9%
Double mutation
9%
RNA-based
9%
Reverse Transcription
9%
Tumor Protein p53 (TP53)
9%
Tumor Tissue
9%
Cancer Types
9%
RNA-DNA
9%
Prostate Tissue
9%
Non-radioactive
9%
Human Carcinoma
9%
Abnormal Migration
9%
Gene Abnormality
9%
Polyacrylamide Gel
9%
Isotopically Labeled
9%
Intratumoral Heterogeneity
9%
P53 Tumor Suppressor Gene
9%
DNA Polymerase Chain Reaction
9%
Small Fragments
9%
Tumor Fragment
9%
Tumor Heterogeneity
9%
Product DNA
9%
Biochemistry, Genetics and Molecular Biology
P53
100%
Complementary DNA
100%
Single-Strand Conformation Polymorphism
100%
Genomics
100%
RNA
55%
Protein P53
55%
Reverse Transcription Polymerase Chain Reaction
44%
Wild Type
22%
Polymerase Chain Reaction
22%
Tumor Suppressor Gene
11%
Gene Mutation
11%
Exon
11%
Reverse Transcription
11%
Coding Region
11%
DNA Polymerase
11%
Pharmacology, Toxicology and Pharmaceutical Science
Complementary DNA
100%
Prostate Cancer
100%
Protein P53
100%
Genomic DNA
100%
Carcinoma
57%
Neoplasm
21%
Malignant Neoplasm
7%
DNA Polymerase
7%
Tumor Suppressor Protein
7%
Polyacrylamide Gel
7%
Food Science
Polymerase Chain Reaction
100%
Reverse Transcription Polymerase Chain Reaction
40%
Veterinary Science and Veterinary Medicine